Correspondence 0001493152-24-010774 from CancerVAX, Inc. (CIK 0001905495)

CancerVAX, Inc. (CIK 0001905495)
Date: March 21, 2024 · CIK: 0001905495 · Accession: 0001493152-24-010774

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 024-12369

Date

March 11, 2024

Author

CANCERVAX

Form

CORRESP

Company

CancerVAX, Inc. (CIK 0001905495)

Letter

Re: CancerVAX, Inc.

March 21, 2024

Via EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F Street, N.E.

Washington, DC 20549

Offering Statement on Form 1-A/A

Filed March 11, 2024

File No. 024-12369

Ladies and Gentlemen:

On behalf of CANCERVAX, INC. (the “Company”), I hereby request qualification of the Company’s above referenced Offering Statement at 4:00pm Eastern Time, on Friday, March 22, 2024, or as soon thereafter as is practicable.

Very
truly yours,
CANCERVAX,
INC.

Show Raw Text

CORRESP
1
filename1.htm

March
21, 2024

Via
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
DC 20549

    Re:
    CancerVAX,
    Inc.

    Offering
    Statement on Form 1-A/A

    Filed
    March 11, 2024

    File
    No. 024-12369

Ladies
and Gentlemen:

On
behalf of CANCERVAX, INC. (the “Company”), I hereby request qualification of the Company’s above referenced Offering
Statement at 4:00pm Eastern Time, on Friday, March 22, 2024, or as soon thereafter as is practicable.

Very
truly yours,

CANCERVAX,
INC.

  /s/
  Byron Elton

  Byron Elton, CEO

SecProbe.io